Cited 0 times in
Cited 0 times in
ADRIATIC: Durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.